Gabather AB (publ) (STO:GABA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0538
+0.0036 (7.17%)
May 23, 2025, 2:50 PM CET
-96.78%
Market Cap 11.86M
Revenue (ttm) n/a
Net Income (ttm) -7.75M
Shares Out 236.20M
EPS (ttm) -0.37
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 343,709
Average Volume 331,640
Open 0.0510
Previous Close 0.0502
Day's Range 0.0492 - 0.0540
52-Week Range 0.0278 - 1.8700
Beta -0.08
RSI 53.44
Earnings Date May 2, 2025

About Gabather AB

Gabather AB (publ), a pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer’s disease. The company develops GT-002 for the treatment of schizophrenia, major depressive disorder, orphan drug, and alzheimer´s disease. It has a collaborative agreement with the Centre for Neuropsychiatric Schizophrenia Research at the Psychiatr... [Read more]

Sector Healthcare
Founded 2014
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol GABA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.